Versant Capital Management, Inc Haemonetics Corp Transaction History

Versant Capital Management, Inc

  • $454 Million
  • Q4 2024

A detailed history of Versant Capital Management, Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 29 shares of HAE stock, worth $2,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Previous 7 314.29%
Holding current value
$2,285
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025
BUY
$71.16 - $93.38 $1,565 - $2,054
22 Added 314.29%
29 $2,000
Q3 2023

Oct 11, 2023
SELL
$82.56 - $93.49 $412 - $467
-5 Reduced 41.67%
7 $0
Q2 2023

Jul 10, 2023
BUY
$80.84 - $89.45 $242 - $268
3 Added 33.33%
12 $1,000
Q2 2020

Jul 16, 2020
SELL
$84.96 - $118.91 $934 - $1,308
-11 Reduced 55.0%
9 $0
Q3 2019

Oct 18, 2019
SELL
$117.16 - $138.52 $1,054 - $1,246
-9 Reduced 31.03%
20 $2,000
Q2 2019

Jul 16, 2019
SELL
$81.74 - $120.34 $9,808 - $14,440
-120 Reduced 80.54%
29 $3,000
Q1 2019

Apr 23, 2019
BUY
$83.25 - $102.12 $11,322 - $13,888
136 Added 1046.15%
149 $13,000
Q1 2019

Apr 23, 2019
SELL
$83.25 - $102.12 $30,636 - $37,580
-368 Reduced 96.59%
13 $13,000
Q4 2018

Jan 29, 2019
SELL
$90.66 - $116.63 $906 - $1,166
-10 Reduced 2.56%
381 $38,000
Q3 2018

Oct 15, 2018
SELL
$89.96 - $114.58 $3,778 - $4,812
-42 Reduced 9.7%
391 $44,000
Q2 2018

Jul 06, 2018
SELL
$71.53 - $95.75 $1,573 - $2,106
-22 Reduced 4.84%
433 $38,000
Q1 2018

Apr 19, 2018
SELL
$60.72 - $74.41 $364 - $446
-6 Reduced 1.3%
455 $33,000
Q4 2017

Apr 19, 2018
BUY
$44.96 - $58.99 $6,249 - $8,199
139 Added 43.17%
461 $26,000
Q3 2017

Apr 23, 2018
BUY
$40.38 - $44.87 $444 - $493
11 Added 3.54%
322 $14,000
Q2 2017

Apr 23, 2018
BUY
N/A
83 Added 36.4%
311 $12,000
Q1 2017

Apr 23, 2018
SELL
N/A
-7 Reduced 2.98%
228 $9,000
Q4 2016

Apr 23, 2018
SELL
N/A
-82 Reduced 25.87%
235 $9,000
Q3 2016

Apr 23, 2018
BUY
N/A
151 Added 90.96%
317 $11,000
Q2 2016

Apr 23, 2018
SELL
N/A
-101 Reduced 37.83%
166 $4,000
Q1 2016

Apr 23, 2018
SELL
N/A
-11 Reduced 3.96%
267 $9,000
Q4 2015

Apr 23, 2018
BUY
N/A
278
278 $8,000

Others Institutions Holding HAE

# of Institutions
332
Shares Held
53.8M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.04B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email